Who are we?
TxCell develops unique cellular immunotherapy platforms based on antigen-specific regulatory T cells for the treatment of severe autoimmune and inflammatory diseases as well as transplantation-related inflammatory disorders
Who are we?
TxCell develops unique cellular immunotherapy platforms based on antigen-specific regulatory T cells for the treatment of severe autoimmune and inflammatory diseases as well as transplantation-related inflammatory disorders